The CooP peptide has been selected by the in vivo screening of a phage display library and classified as a glioblastoma homing peptide, with the mammary-derived growth inhibitor (MDGI/FABP3) identified as its interacting partner [14,15]. The gene discussed is FABP3; the disease is glioblastoma.